Combination Therapy Dose Optimization in Oncology Trials
Design, modeling, and operational considerations for biotech and pharma
SOLUTIONS
-
Hospital Solutions
-
Business Intelligence and Data Science
-
Commercial Services for Optimal Performance
-
Commercial Engagement Services
-
Commercial Support Solutions
-
Commercial Technologies
-
Real World Evidence
-
Activation Services
-
Clinical Research & Development Solutions
Hospital Solutions
Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?
OverviewKey Solutions for Hospitals
Business Intelligence and Data Science
As part of the global healthcare community, IQVIA Belgium and its BIDS team (Business Intelligence and Data Science) continuously invest in ways to help life science companies find the next breakthrough in improving human health.
OverviewKey Solutions for Bids
Commercial Services for Optimal Performance
Given the dynamic marketplace, your need to rely on sound information has never been greater. You must make fast decisions without delay. Innovate without undue risk. Execute without faltering.
OverviewKey solutions
Commercial Engagement Services
We can help you get your product to patients quickly. This is done by finding the right candidates to help you in assembling a qualitative team that is trained and equipped with the best tools & applications. With the unique IQVIA approach, we can also make sure you target the right healthcare providers.
OverviewKey solutions
Commercial Support Solutions
IQVIA helps our customers generate real world evidence (RWE) to unlock the value of their investment at every stage of the product life cycle.
OverviewCommercial Technologies
Let yourself be guided and get in direct contact with your key partners in your market. With IQVIA Pharm In Touch, IQVIA Dental In Touch, IQVIA MobiRep and integrated services, you will have even more freedom of movement.
OverviewReal World Evidence
IQVIA helps our customers generate real world evidence (RWE) to unlock the value of their investment at every stage of the product life cycle.
OverviewActivation Services
As the essential partner for pharmacists and pharmaceutical companies we offer effective activation services and marketing tools to meet today's challenges. The Activation Services department of IQVIA is specialised in pharmacy communication and puts its expertise at the service of its partners.
OverviewClinical Research & Development Solutions
Reimagine clinical development by intelligently connecting data, technology and analytics to optimize your trials. The result? Faster decision making, innovation with reduced risk and driving trials without compromise so you can deliver life-changing therapies faster.
OverviewKey solutions
PRODUCTS
-
Pharmaceutical company
Are you a pharmaceuticals ?
IQVIA is a world leader in using data, technology, advanced analytics and human expertise.
OverviewCareers Belgium
Why work at IQVIA Belux? Help create a healthier world—start right here where we offer a diverse selection of opportunities.
Learn moreExplore our Roles
We understand that part of your role involves spending a lot of time on the road, which is why at IQVIA we give you the opportunity to schedule your own agenda.
Learn moreBlog
Shifting the paradigm: unlocking early-stage oncology opportunities
Jun 27, 2025
In oncology, the stage of disease determines the treatment intent—curative in early stages, palliative in advanced ones. While staging systems vary by cancer type, the trend toward earlier intervention is gaining momentum across Europe, including Belgium. This shift is reshaping how pharmaceutical companies approach development, access, and commercialization.
Why earlier matters
Belgium’s healthcare system is known for its strong clinical infrastructure and early adoption of innovation. Treating cancer at an earlier stage not only improves patient outcomes but also aligns with the country’s focus on value-based care and cost-effective treatment pathways. However, this evolution raises important questions for pharma stakeholders.
Key questions for pharma leaders
- How can we demonstrate value in early-stage populations within Belgium’s reimbursement framework?
- What local evidence is needed to support earlier intervention?
- How do we engage oncologists and hospitals in early-stage treatment adoption?
- What role can real-world data play in supporting earlier access?
Partnering for progress: IQVIA’s local expertise
At IQVIA, we believe in empowering pharmaceutical teams with the insights, tools, and partnerships needed to bring transformative therapies to patients earlier in their journey. In Belgium, our local experts work closely with clients to navigate the unique dynamics of the healthcare system.
1. Illuminating the patient experience
We help map the early-stage oncology journey in Belgium, identifying key decision points and treatment flows. Our sentiment analysis captures the perspectives of Belgian patients, caregivers, and HCPs to inform tailored strategies.
2. Turning data into direction
IQVIA Belgium integrates local clinical and real-world data with global analytics to uncover actionable insights. Our tools support predictive modeling and real-time feedback to guide early-stage planning.
3. Navigating access with confidence
Our HEOR and market access teams support early dialogue with RIZIV/INAMI and other stakeholders. We help demonstrate value through local outcomes research and ensure alignment with Belgian reimbursement criteria.
4. Engaging the ecosystem
Early-stage success depends on strong connections. We help identify and engage the right experts, institutions, and influencers through tailored KOL and HCO mapping, and support omnichannel strategies that resonate across touchpoints
5. Enabling innovation through technology
From AI-driven personalization to telehealth platforms, we support pharma teams in delivering education, adherence tools, and patient support programs tailored to local needs.
Actionable tips for pharma teams
- Engage early with stakeholders: involve RIZIV/INAMI, oncologists, and patient groups early in the development process to align on value and access.
- Leverage local real-world data: use Belgian treatment and outcomes data to support early-stage positioning and reimbursement submissions.
- Map regional treatment dynamics: understand how early-stage care varies across Flanders, Wallonia, and Brussels to tailor your strategy.
- Collaborate with local experts: IQVIA BeLux offers deep expertise in HCO mapping, treatment initiator identification, and sentiment analysis specific to the Belgian context.
Ready to lead the shift to early-stage oncology? IQVIA is here to help you lead it, with data, insight, and local expertise.
Reach out to us for more information or to discuss how we can support your shift to early-stage oncology: kristin.vandendaele@iqvia.com or sophie.tigranoff@iqvia.com